Monthly reports

State of Peptide Vendors

One edition a month. Each report counts vendor statuses and the month's changes from the vendor status log, tabulates closures by year, and records a dated snapshot of cross-vendor per-mg prices from the price registry. Figures are computed from the published datasets; the summary is written by hand. For research and journalistic reference.

  1. October 2026Published Oct 24, 2026

    October 2026 is the first edition of this report. No vendor in the status log changed status during October; the three September 2026 closures (Chemyo, Eternal Peptides, Chameleon Peptides) were documented and added to the log on October 19, 2026, which is why they appear as this month’s additions. On the regulatory side, an HHS/FDA notice titled "Interim Access Policy for Compounding Using Certain Peptides" reached OMB review on October 14, 2026. The price snapshot below is the first in the series, so no month-over-month deltas are shown yet.